Patent: 4,496,537
✉ Email this page to a colleague
Summary for Patent: 4,496,537
Title: | Biologically stable alpha-interferon formulations |
Abstract: | The addition of glycine or alanine prior to lyophilization significantly improves the biological stability of alpha type interferon formulations. |
Inventor(s): | Kwan; Henry K. (Summit, NJ) |
Assignee: | Schering Corporation (Madison, NJ) |
Application Number: | 06/532,886 |
Patent Claims: | see list of patent claims |
Details for Patent 4,496,537
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2002-11-19 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2002-11-19 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2002-11-19 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 4,496,537
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 8209344 | ⤷ Try a Trial |
South Africa | 8208580 | ⤷ Try a Trial |
Singapore | 70687 | ⤷ Try a Trial |
Portugal | 76013 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |